GlassScriptPhysician profile
Maris R Davis
NPI 1841381076
$5,557.01
in general payments reported to CMS, 2019-2025
43 companies · $1,683 in 2025
The $1,683 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,066 · 2020: $616 · 2021: $11.50 · 2022: $11.71 · 2023: $429 · 2024: $739 · 2025: $1,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,812 · Education: $39.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,811.93 |
| Education | $39.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $943.77 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Corcept Therapeutics | $645.98 | 2019-2025 | Korlym |
| Lilly USA, LLC | $479.49 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Sanofi-Aventis U.S. LLC | $427.71 | 2019-2025 | |
| Amgen INC. | $306.68 | 2019-2025 | Evenity, Tepezza, Krystexxa |
| Abbott Laboratories | $301.88 | 2019-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $268.83 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $207.52 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $182.83 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $174.40 | 2019-2020 | |
| Radius Health, INC. | $168.42 | 2019-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.43 | 2019-2025 | Jardiance |
| Medtronic Minimed, INC. | $144.20 | 2019 | |
| Mannkind Corporation | $101.03 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.06 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maris Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.